SALLIE J WALKER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ARDMORE, OK NPI 1306889878
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family OK Acerta Pharma LLC All categories
General Payments — all program years on this page
$4,761.35
- Category: General Payments
- Program years: PY2021–2024
- Record count: 233
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,195.19 across 59 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,195.19 | 59 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $134.70 | 7 |
| PFIZER INC. | $129.13 | 7 |
| Merck Sharp & Dohme Corporation | $116.39 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $89.75 | 4 |
| EISAI INC. | $81.18 | 4 |
| Janssen Biotech, Inc. | $71.99 | 3 |
| GENZYME CORPORATION | $62.81 | 3 |
| E.R. Squibb & Sons, L.L.C. | $57.18 | 3 |
| SOBI, INC | $56.38 | 3 |
| Stemline Therapeutics Inc. | $53.86 | 2 |
| Astellas Pharma US Inc | $51.20 | 3 |
| Lilly USA, LLC | $34.86 | 2 |
| Incyte Corporation | $34.73 | 2 |
| Regeneron Healthcare Solutions, Inc. | $30.00 | 1 |
| TerSera Therapeutics LLC | $29.28 | 1 |
| ARRAY BIOPHARMA INC | $24.71 | 1 |
| Daiichi Sankyo Inc. | $22.74 | 1 |
| Celgene Corporation | $19.99 | 1 |
| Genentech USA, Inc. | $17.75 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.86 | 1 |
| Mirati Therapeutics, Inc. | $16.84 | 1 |
| MENARINI SILICON BIOSYSTEMS, INC. | $15.21 | 1 |
| Gilead Sciences, Inc. | $14.44 | 1 |
| Myriad Genetic Laboratories, Inc. | $13.21 | 1 |
By program year
Records — PY2024 (59)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.